Balance Sheet

Current Liabilities	169.1m
Accounts Payable	113m
Accrued Liabilities	21.6m
Other Current Liabilities	34.5m
Non-Current Liabilities	34.1m
Long-Term Debt	12.6m
Other Non-Current Liabilities	21.5m

Currency: CNY

	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022
Assets
Cash & Cash Equivalents	97	49	64	423	383	1 154	523
Cash	0	0	0	0	0	1 154	523
Cash Equivalents	97	49	63	423	383	0	0
Short-Term Investments	0	0	0	0	0	927	889
Total Receivables	12	21	32	51	35	86	124
Accounts Receivables	11	17	26	38	27	37	96
Other Receivables	1	5	5	13	9	49	28
Inventory	11	22	30	66	126	259	154
Other Current Assets	2	4	4	10	44	92	108
Total Current Assets	121	96	130	549	588	2 518	1 798
PP&E Net	33	79	118	157	243	590	944
PP&E Gross	33	79	118	157	243	590	944
Accumulated Depreciation	14	24	39	56	70	95	200
Intangible Assets	0	10	11	11	58	57	57
Long-Term Investments	0	0	0	0	0	442	1 038
Other Long-Term Assets	5	4	9	9	14	38	62
Total Assets	160 N/A	190 +18%	267 +41%	726 +172%	903 +24%	3 645 +304%	3 899 +7%
Liabilities
Accounts Payable	6	8	12	12	72	178	263
Accrued Liabilities	9	9	10	12	30	135	146
Short-Term Debt	3	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	0	3	0	13	28
Other Current Liabilities	10	12	35	19	43	409	74
Total Current Liabilities	28	28	56	46	144	734	511
Long-Term Debt	0	0	0	21	0	23	14
Deferred Income Tax	0	0	1	1	2	4	9
Minority Interest	0	0	1	4	4	30	18
Other Liabilities	1	0	0	9	10	9	11
Total Liabilities	29 N/A	28 -4%	57 +105%	81 +40%	160 +99%	801 +401%	564 -30%
Equity
Common Stock	47	47	47	62	62	62	92
Retained Earnings	25	55	104	137	231	2 323	2 958
Additional Paid In Capital	59	60	60	446	450	458	435
Treasury Stock	0	0	0	0	0	0	150
Other Equity	0	0	0	0	0	0	0
Total Equity	131 N/A	162 +23%	210 +30%	645 +208%	743 +15%	2 844 +283%	3 335 +17%
Total Liabilities & Equity	160 N/A	190 +18%	267 +41%	726 +172%	903 +24%	3 645 +304%	3 899 +7%
Shares Outstanding
Common Shares Outstanding	47	47	47	62	62	92	90

Beijing Hotgen Biotech Co Ltd
SSE:688068